Bhatnagar, B., Sun, Z., Mattison, R., Paietta, E., Zhang, Y., Racevskis, J., Lazarus, H., Rowe, J., Arber, D., Wieduwilt, M., Liedtke, M., Bergeron, J., Wood, B., Pratz, K., Dinner, S., Frey, N., Gore, S., Atallah, E., Uy, G., Jeyakumar, D., Lin, T., Willman, C., Podoltsev, N., Deangelo, D., Patel, S., Elliott, M., Advani, A., Tzachanis, D., Vachhani, P., Roy, R., Sharon, E., Little, R., Erba, H., Stone, R., Luger, S., Mullighan, C., Tallman, M., Litzow, M. (2025). Impact of therapy delays on outcomes in adults with BCR::ABL1 negative b-lineage acute lymphoblastic leukemia (ALL) in the ECOG-ACRIN E1910 trial randomized to conventional chemotherapy +/- blinatumomab. Blood. https://doi.org/10.1182/blood-2025-1549